Quantcast

Latest Teva Pharmaceutical Industries Ltd. Stories

2014-10-09 16:27:58

ADASUVE Initial Product Inventory Stocking Completed MOUNTAIN VIEW, Calif., Oct. 9, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on the U.S. commercial progress with ADASUVE(®) (loxapine) inhalation powder (Staccato(®) loxapine). Teva Pharmaceutical Industries Ltd. is Alexza's commercial partner for ADASUVE in the United States. Teva and Alexza announced the commencement of the U.S. launch of ADASUVE in March 2014. "During the third quarter, we...

2014-08-28 12:29:56

PITTSBURGH, Aug. 28, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration (FDA). This product is the generic version of Teva's Copaxone® 40 mg/mL, which is indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS)....

2014-08-21 16:24:50

ENSPIRIT Trial to Continue as Planned Following Completion of the First of Two Interim Futility Analyses BOTHELL, Wash. and VANCOUVER, British Columbia, Aug. 21, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Phase 3 ENSPIRIT trial, evaluating custirsen in the treatment of non-small cell lung cancer (NSCLC), is continuing as planned per the recommendation of the Independent Data Monitoring Committee (IDMC) based upon completion of the...

2014-08-14 16:26:38

DUBLIN, Aug. 14, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Contraceptives Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Contraception, also known as birth control or fertility control, refers to the use of methods or drugs or devices to prevent pregnancy as a consequence of sexual intercourse. Contraception methods can be temporary and permanent and are available to men and women. Permanent methods...

2014-07-31 12:29:00

DUBLIN, July 31, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Parkinson's Disease Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Parkinson's disease is a progressive neurodegenerative disorder characterized by damage of dopaminergic neurons located in various parts of brain including the substantia nigra. This lowers the concentration of dopamine in the striatum. A decrease in dopamine levels by 80 percent...

2014-06-23 12:28:46

LONDON, June 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Testicular Cancer Drugs Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_testicular_cancer_drugs_market_2014_2018.html TechNavio's analysts forecast the Global Testicular Cancer Drugs market to grow at a CAGR of 4.02 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of testicular...

2014-05-20 08:29:12

LONDON, May 20, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Generic Drugs Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/generic_drugs/global_generic_drugs_market_2014_2018.htmlTechNavio's analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this market. The market is...

2014-05-09 20:23:13

DUBLIN, May 10, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/xrtmp7/global) has announced the addition of the "Global Biosimilars Market 2014-2018" [http://www.researchandmarkets.com/research/xrtmp7/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Biosimilars Market to grow at a CAGR of 27.58 percent over the period 2013-2018. One of the key...

2014-05-01 08:37:39

DUBLIN, May 1, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sdjlqk/global_generic) has announced the addition of the "Global Generic Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this...

2014-04-25 16:23:54

Editor Note: For more information about this release, please scroll to bottom. LONDON, April 25, 2014 /PRNewswire/ -- On Thursday, April 24, 2014, the NASDAQ Composite ended at 4,148.34, up 0.52%, the Dow Jones Industrial Average finished the day flat at 16,501.65, and the S&P 500 closed at 1,878.61, up 0.17%. The gains were narrow based as four out of the ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 668.80, down...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related